News
Good news bracketed July for Teleflex Inc. as it completed the acquisition of the vascular intervention business of ...
Lepu Biopharma Co. Ltd. has out-licensed two preclinical T-cell engagers to Shanghai-based newco Excalipoint in a deal worth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results